Pulmonary Medicine / 2021 / Article / Tab 2

Research Article

Safety and Feasibility of a Novel Protocol for Percutaneous Dilatational Tracheostomy in Patients with Respiratory Failure due to COVID-19 Infection: A Single Center Experience

Table 2

Clinical characteristics of COVID-19 patients undergoing PDT.

VariablePDT patients ()

Age (y)
Gender (male/female)16/16
Body mass index (kg/m2) (min 17-max 66)
PCR positive at the time of PDT20, 5 false negative
FIO2 (min 30-max 70)
PEEP (min 5-max 14)
Anticoagulation at the time of PDT24
ECMO at any time/ECMO at time of PDT7/0
Days on ventilator before PDT (min 14-max 39)
Follow-up after PDT (d) (min 4-max 45)
Follow-up after initial intubation (min 22-max 72)
 Weaned from MV18 (56%)
 Remain on MV5 (16%)
 Death9 (28%)